Pharmacokinetics of enteric-coated mycophenolate sodium in Chinese renal transplantation recipients

被引:11
作者
Qiu Kui [2 ]
Tian Hui [1 ]
Wang Wei [1 ]
Hu Xiao-peng [1 ]
Li Xiao-bei [1 ]
Gong Li-li [2 ]
Luo Wei [2 ]
Liu Li-hong [2 ]
Zhang Xiao-dong [1 ]
Yin Hang [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Urol, Kidney Transplantat Program, Beijing 100020, Peoples R China
[2] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharmacol, Beijing 100020, Peoples R China
关键词
enteric-coated mycophenolate sodium; pharmacokinetics; limited sampling strategy; Chinese renal transplant recipients; LIMITED SAMPLING STRATEGIES; GASTROINTESTINAL INTOLERANCE; ACID EXPOSURE; MPA EXPOSURE; MOFETIL; KIDNEY; BIOEQUIVALENCE; PERFORMANCE; VALIDATION; EFFICACY;
D O I
10.3760/cma.j.issn.0366-6999.2012.23.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mycophenolic acid (MPA) as an anti-proliferative immune-suppressive agent is used in the majority of immunosuppressive regimens in solid organ transplantation. This study aimed to investigate the pharmacokinetic (PK) characteristics of enteric-coated mycophenolate sodium (EC-MPS) and area under the curve (AUC) from 0 to 12 hours with limited sampling strategies (LSSs) in Chinese renal transplant recipients. Methods This study was conducted in 10 Chinese renal transplant patients receiving living donor and treated with EC-MPS, cyclosporine, and corticosteroids. MPA concentrations were measured by enzyme multiplied immunoassay technique (EMIT). Whole 12-hour PK profiles were obtained on Day 4 after operation. LSSs with jackknife technique, multiple stepwise regression analysis, and Bland-Altman analysis were developed to estimate MPA AUC. Results The mean maximum plasma concentration, the mean time for it to reach peak (T-max), and the mean MPA AUC were (11.38 +/- 2.49) mg/L, (4.85 +/- 3.32) hours, and (63.19 +/- 13.54) mg.h.L-1, respectively. Among the 10 profiles, MPA AUC of four patients was significantly higher than that of the other six patients, and the corresponding T-max was significantly longer than that of the other six patients. No patient exhibited a second peak caused by enterohepatic recirculation. The best models were as follows: 27.46+0.94C(3)+3.24C(8)+2.81C(10) (r(2)=0.972), which was used to predict AUC of fast metabolizer with a mean prediction error (MPE) of -0.21% and a mean absolute prediction error (MAE) of 2.59%; 36.65+3.08C(8)+5.30C(10)-4.04C(12) (r(2)=0.992), which was used to predict AUC of slow metabolizer with a MPE of 0.58% and a MAE of 1.95%. Conclusions The PKs of EC-MPS had a high variability among Chinese renal transplant recipients. The preliminary PK data indicated the existence of slow and fast metabolizer. These findings may be associated with the enterohepatic recirculation. Chin Med J 2012;125(23):4226-4232
引用
收藏
页码:4226 / 4232
页数:7
相关论文
共 23 条
[1]   Enteric-coated mycophenolate sodium delivers bioequivalent MPA exposure compared with mycophenolate mofetil [J].
Arns, W ;
Breuer, S ;
Choudhury, S ;
Taccard, G ;
Lee, J ;
Binder, V ;
Roettele, J ;
Schmouder, R .
CLINICAL TRANSPLANTATION, 2005, 19 (02) :199-206
[2]   Validation of Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure During the First Year After Heart Transplantation [J].
Baraldo, M. ;
Cojutti, P. G. ;
Isola, M. ;
Feruglio, M. T. ;
Tursi, V. ;
Livi, U. ;
Furlanut, M. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) :4277-4284
[3]   Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration [J].
Bullingham, R ;
Monroe, S ;
Nicholls, A ;
Hale, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :315-324
[4]  
Capone D, 2011, NEPHROL DIAL TRANSPL, V9, P1
[5]   Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney [J].
Cattaneo, Dario ;
Cortinovis, Monica ;
Baldelli, Sara ;
Bitto, Alessandra ;
Gotti, Eliana ;
Remuzzi, Giuseppe ;
Perico, Norberto .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (06) :1147-1155
[6]   Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus [J].
Djabarouti, Sarah ;
Duffau, Pierre ;
Lazaro, Estibaliz ;
Chapouly, Candice ;
Greib, Carine ;
Viallard, Jean-Francois ;
Pellegrin, Jean-Luc ;
Saux, Marie-Claude ;
Breilh, Dominique .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (05) :689-699
[7]   Better mycophenolic acid 12-hour trough level after enteric-coated mycophenolate sodium in patients with gastrointestinal intolerance to mycophenolate mofetil [J].
Fructuoso, A. Sanchez ;
Calvo, N. ;
Moreno, M. A. ;
Giorgi, M. ;
Conesa, J. ;
Barrientos, A. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) :2194-2196
[8]   Renal function of donors and recipients after living donor kidney transplantation in a Chinese cohort [J].
Gong Nian-qiao ;
Ming Chang-sheng ;
Zeng Fan-jun ;
Zhang Wei-jie ;
Lin Zhen-bin ;
Zhou Ping ;
Chen Xiao-ping ;
Chen Zhi-shui .
CHINESE MEDICAL JOURNAL, 2011, 124 (09) :1290-1295
[9]   Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay [J].
Hosotsubo, H ;
Takahara, S ;
Imamura, R ;
Kyakuno, M ;
Tanaka, T ;
Yazawa, K ;
Hanafusa, T ;
Matsumiya, K ;
Nonomura, N ;
Okuyama, A ;
Sugimoto, H .
THERAPEUTIC DRUG MONITORING, 2001, 23 (06) :669-674
[10]   Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies [J].
Jiao, Zheng ;
Zhong, Jian-yong ;
Zhang, Ming ;
Shi, Xiao-jin ;
Yu, Yun-qiu ;
Lu, Wei-yue .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) :27-37